Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Simian adenoviral vectors (SAd) offer an attractive alternative to standard human adenovirus serotype 5 (AdH5) subunit vaccination, due to pre-existing immunity affecting vaccine performance. We have used a mouse model of liver-stage malaria to test the efficiency of three chimpanzee-origin adenovir...
Үндсэн зохиолчид: | Reyes-Sandoval, A, Sridhar, S, Berthoud, T, Moore, A, Harty, J, Gilbert, S, Gao, G, Ertl, H, Wilson, J, Hill, A |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2008
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
-н: Reyes-Sandoval, A, зэрэг
Хэвлэсэн: (2011) -
Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
-н: Reyes-Sandoval, A, зэрэг
Хэвлэсэн: (2005) -
Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.
-н: Sridhar, S, зэрэг
Хэвлэсэн: (2008) -
Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
-н: Folegatti, PM, зэрэг
Хэвлэсэн: (2019) -
NEUTRALIZING ANTIBODY TITERS TO SIMIAN ADENOVIRAL VECTORS FOLLOWING ADCH63 ME-TRAP IMMUNIZATION IN HUMANS
-н: Goodman, A, зэрэг
Хэвлэсэн: (2009)